James McArthur is an American businessman and entrepreneur. He is the current chief executive officer of PepGen. He leads a top pharmaceutical research company that works to develop a new generation of oligonucleotide therapeutics for treating neurologic and neuromuscular diseases. His journey to the executive level of leadership began with his passion for research and finding treatments for cancers and other diseases that interfere with the duration and quality of life. We looked into his personal and career history and learned a great deal about how he came to be successful in business. Here are ten things you probably didn’t know about James McArthur you may find inspiring.
1. James McArthur is also a consultant
Crunchbase confirms that McArthur is not only the leader of PepGen, but he also served as a consultant in the financial and biotech industries. He consulted for many venture capital groups throughout his career because of his expertise in biotechnology. He is in high demand for his advisement on financial matters in the biotech industry.
2. He is influential in the biotech industry
James McArthur served on many boards of directors as an advisor, in addition to working as a consultant. Mr. McArthur was a member of Friedrich’s Ataxia Research Alliance Advisory Board. he also served on the T-Cure Biosciences board of directors in the position of director from April 2020 through September 2020. He shared his opinions with the boards, advising leaders in financial and strategic planning.
3. James McArthur has founded two companies
McArthur is also a serial entrepreneur. He is the founder of a company called Tiburio Therapeutics from 2018 through 2019. The company’s headquarters are in Cambridge, Massachusets, developing drug compounds to treat endocrine diseases and tumors. the company raised $31 million. He co-founded a company called Vtesse, the developer of a drug that showed promise for treating Niemann-Pick Disease. The Gaithersburg, Maryland company raised funding of $42 million before it was acquired by Sucampo Pharmaceuticals for an undisclosed amount.
4. He served as a senior scientist
James McArthur has the knowledge to lead in the business end of biotech companies because of his previous work in the field. He is an actual scientist who understands the challenges and promises that biotech companies can offer the world. He served as a senior scientist for a company called Somatix Therapy. The biotech organization is engaged in the research and development of proprietary processes for the genetic modification of cells. The Alameda, California company was acquired by Cell Genesys.
5. He is a McGill University graduate
McArthur enrolled in higher education in 1980. He spent four years working toward his first college degree. He earned his bachelor of science degree in 1984 from McGill University where he studied biochemistry.
6. James McArthur earned his doctorate
After completing his BSC in biochemistry, McGill continued his education at McGill University in the Ph.D. program. He attended the graduate school from 1984 through 1989, graduating with his doctoral degree in Molecular Oncology. His studies focused on identifying genetic elements in leukemia that cause gene instability and amplification.
7. James McArthur has years of post-doctoral education to his credit
According to his LinkedIn profile, McArthur continues with post-doctoral studies at the Massachusetts Institute of Technology from 1989 to 1991. He researched T helper cell activation IL-6 signals. James McArthur not only earned his doctoral degree, but he has also engaged in formal studies beyond that level of degree in pursuit of his passion for unlocking the mysteries that hold the potential to cure some of the most deadly diseases that plague mankind. He also enrolled in a post-doctoral study program in immunology at the University of California, Berkeley. He attended the school from 1991 through 1993 conducting further research in T helper cell activation signals for CD29 costimulation. James McArthur completed four years of education in the field of biotechnical research and development. he is a lifelong learner and continues to build his knowledge base in the pursuit of finding cures or treatments for several different diseases.
8. He founded Cydan with numerous satellite companies
In addition to the other two companies McArther founded, he also established a biotech company called Cydan. He was not only the founder of the business, but he also served as the president of research and development from September 2017 through August 2020. Cydan is headquartered in Cambridge, Massachusetts. The biotech company focuses on the development of therapies to treat rare diseases. As the founder of Cydan, McArthur was also the founder of three other companies that launched under the umbrella of Cydan. Vtesse, Imara, and Tiburio conducted similar research and development in separate areas of the biotech field with related benefits in the field of genetics. Cydan served as the accelerator company for the launch, growth, and development of the other three. He is truly a serial entrepreneur.
9. James McArthur is a well-balanced person
James McArthur has a lot going on in his professional life. It’s apparent by reading his educational and career history that he has been busy with studies and research for most of his adult life. Although he’s worked hard and dedicated his life to biotech research and development, he has also made time for things that he enjoys doing in his personal life. We learned that there are a great many activities that McArthur enjoys and makes time for. Among them are distance cycling, scuba diving, camping in the summer and the winter, and rock climbing. The things that he enjoys doing are physical activities that promote physical fitness. He’s a well-rounded person who balances his personal and professional aspects.
10. James McArthur is an inventor with patents
Justia confirms that James McArthur has filed for more than twenty patents throughout his career. He secured the rights to the intellectual properties he created through his research and development processes for developing treatments for various medical conditions. Some of his patented properties relate to treatments for sickle cell anemia, peripheral diseases, cancer-related antigens, liver enhancers, and many more.